Hydroxypropyl-β-Cyclodextrin Formulated in Nasal Chitosan Microspheres as Candidate Therapeutic Agent in Alzheimer's Disease

Curr Drug Deliv. 2018;15(6):746-748. doi: 10.2174/1567201814666171019104509.

Authors

Giovanna Rassu¹, Elisabetta Gavini¹, Antonio Carta¹, Antonella Obinu², Elena Piera Porcu¹, Paolo Giunchedi¹

Affiliations

¹ Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy.
² University of Pavia, PhD School of Experimental Medicine, Pavia, Italy.

PMID: 29065835
DOI: 10.2174/1567201814666171019104509

No abstract available

MeSH terms

2-Hydroxypropyl-beta-cyclodextrin / administration & dosage*
Administration, Intranasal
Alzheimer Disease / drug therapy*
Chitosan / chemistry
Drug Carriers / chemistry*
Drug Compounding / methods
Humans
Microspheres
Neuroprotective Agents / administration & dosage*
Orphan Drug Production

Substances

Drug Carriers
Neuroprotective Agents
2-Hydroxypropyl-beta-cyclodextrin
Chitosan